Cargando…

PRO‐C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD

Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease in children and may lead to cirrhosis requiring liver transplant. Thus, prompt diagnosis of advanced fibrosis is essential. Our objectives were to examine PRO‐C3 (a neo‐epitope pro‐peptide of type III collagen formation) leve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohen, Catherine C., Castillo‐Leon, Eduardo, Farris, Alton B., Caltharp, Shelley A., Cleeton, Rebecca L., Sinclair, Elizabeth M., Shevell, Diane E., Karsdal, Morten A., Nielsen, Mette Juul Fisker, Leeming, Diana J., Vos, Miriam B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557318/ https://www.ncbi.nlm.nih.gov/pubmed/34558828 http://dx.doi.org/10.1002/hep4.1766

Ejemplares similares

Quantification of extracellular matrix remodeling for the non-invasive identification of graft fibrosis after liver transplantation
por: Engel, Bastian, et al.
Publicado: (2023)

Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis
por: Erhardtsen, Elisabeth, et al.
Publicado: (2021)

Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model
por: Veidal, Sanne Skovgård, et al.
Publicado: (2012)

Natural History of NAFLD Diagnosed in Childhood: A Single-Center Study
por: Cioffi, Catherine E., et al.
Publicado: (2017)

Serological Investigation of the Collagen Degradation Profile of Patients with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis
por: Leeming, Diana J., et al.
Publicado: (2012)

Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients
por: Nielsen, Mette Juul, et al.
Publicado: (2019)

Molecular Serum Markers of Liver Fibrosis
por: Liu, Tianhui, et al.
Publicado: (2012)

Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis
por: Jessen, Henrik, et al.
Publicado: (2021)

PRO‐C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol‐related liver disease
por: Madsen, Bjørn S., et al.
Publicado: (2021)

Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation
por: Thiele, Maja, et al.
Publicado: (2021)

Serological Assessment of Activated Fibroblasts by alpha-Smooth Muscle Actin (α-SMA): A Noninvasive Biomarker of Activated Fibroblasts in Lung Disorders()()
por: Holm Nielsen, Signe, et al.
Publicado: (2018)

What is the best way to measure renal fibrosis?: A pathologist's perspective
por: Farris, Alton B, et al.
Publicado: (2014)

A serological marker of the N-terminal neoepitope generated during LOXL2 maturation is elevated in patients with cancer or idiopathic pulmonary fibrosis
por: Leeming, D.J., et al.
Publicado: (2018)

BMS‐986263 in patients with advanced hepatic fibrosis: 36‐week results from a randomized, placebo‐controlled phase 2 trial
por: Lawitz, Eric J., et al.
Publicado: (2021)

The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?
por: Genovese, Federica, et al.
Publicado: (2014)

Serological assessment of collagen fragments and tumor fibrosis may guide immune checkpoint inhibitor therapy
por: Jensen, Christina, et al.
Publicado: (2021)

Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients
por: Nielsen, Mette J., et al.
Publicado: (2015)

Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART
por: Dold, Leona, et al.
Publicado: (2019)

Quantitative assessment of liver fibrosis by digital image analysis reveals correlation with qualitative clinical fibrosis staging in liver transplant patients
por: Jiang, Kun, et al.
Publicado: (2020)

Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021)

PRO-C3-Levels in Patients with HIV/HCV-Co-Infection Reflect Fibrosis Stage and Degree of Portal Hypertension
por: Jansen, Christian, et al.
Publicado: (2014)

Renal Medullary and Cortical Correlates in Fibrosis, Epithelial Mass, Microvascularity, and Microanatomy Using Whole Slide Image Analysis Morphometry
por: Farris, Alton B., et al.
Publicado: (2016)

Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis
por: Jessen, H., et al.
Publicado: (2021)

Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness
por: Liebig, Stephanie, et al.
Publicado: (2019)

Risk of severe illness of COVID‐19 patients with NAFLD and increased NAFLD fibrosis scores
por: Yao, Renling, et al.
Publicado: (2021)

Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinoma
por: Leeming, Diana Julie, et al.
Publicado: (2020)

Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer
por: Madsen, Emilie A., et al.
Publicado: (2022)

Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD
por: Pearce, Steven G, et al.
Publicado: (2013)

Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLD
por: Sowa, Jan-Peter, et al.
Publicado: (2013)

Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD
por: Sanchez, Jessica I., et al.
Publicado: (2023)

Circulating Levels of a Collagen Type V Propeptide Fragment in a Carbon Tetrachloride Reversible Model of Liver Fibrosis
por: Vassiliadis, E., et al.
Publicado: (2012)

Image Analysis Pipeline for Renal Allograft Evaluation and Fibrosis Quantification
por: Farris, Alton Brad, et al.
Publicado: (2021)

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
por: Bazick, Jessica, et al.
Publicado: (2015)

Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV
por: Dold, Leona, et al.
Publicado: (2023)

Is melatonin associated with pro-inflammatory cytokine activity and liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients?
por: Sohrabi, Masoudreza, et al.
Publicado: (2021)

Serological identification of fast progressors of structural damage with rheumatoid arthritis
por: Siebuhr, Anne Sofie, et al.
Publicado: (2013)

Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD
por: Pantano, Lorena, et al.
Publicado: (2021)

Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD
por: Blomdahl, Julia, et al.
Publicado: (2023)

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
por: Reinson, Tina, et al.
Publicado: (2023)

Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma – A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients
por: Jensen, Christina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ep2pa93v8mr5aof2ulentnbta5